Published in Obesity and Diabetes Week, July 18th, 2005
The randomized, placebo-controlled study will assess efficacy, overall safety and tolerability of Avanir's investigational drug targeting central nervous system (CNS) receptors to treat diabetic neuropathic pain.
The 3-month study will assess the efficacy of Neurodex in relieving pain in adult patients with distal symmetrical diabetic neuropathy with daily pain in the lower extremities. The clinical trial will be conducted at 40 sites in the United States and will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week